Literature DB >> 32119760

Association between arterial hypertension and depressive symptoms: Results from population-based surveys in Peru.

David Villarreal-Zegarra1,2, Antonio Bernabe-Ortiz2,3.   

Abstract

INTRODUCTION: Approximately 350 million people have depression. The presence of arterial hypertension is a major risk factor for mental health. However, several studies on the association between arterial hypertension and depressive symptoms present controversial evidence. We aimed at identifying whether there is an association between arterial hypertension and depressive symptoms, taking into account the time since hypertension diagnosis.
METHODS: A secondary analysis of the Demographic and Health Survey in Peru (2014-2016) was conducted. The outcome was depressive symptoms, while hypertension and time since hypertension diagnosis were the exposure of interest. Poisson regression models were created, reporting prevalence ratios (PR) and 95% confidence intervals (95% CI).
RESULTS: Data from 87 253 participants were analyzed. A total of 2633 (3.0%; 95% CI: 2.8%-3.2%) individuals had depressive symptoms, whereas hypertension was present in 15 681 (19.6%; 95% CI: 19.1%-20.1%) subjects. In the multivariable model, people with less than a year since diagnosis were more than twice as likely to have depressive symptoms (PR = 2.08, 95% CI 1.65-2.63) compared to the group of people without hypertension. This probability decreased for individuals with 1 to 4 years since diagnosis (PR = 1.42, 95% CI 1.13-1.80), and for people with ≥5 years since diagnosis (PR = 1.29, 95% CI 1.01-1.64).
CONCLUSIONS: There is an association between hypertension and depressive symptoms, but this varies depending on time since diagnosis. Thus, individuals with <1 year since diagnosis had the highest probability of having depressive symptoms; after that, that probability decreased as the time since diagnosis increased.
© 2020 John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  circulatory disease; depression; hypertension; mental health

Mesh:

Year:  2020        PMID: 32119760     DOI: 10.1111/appy.12385

Source DB:  PubMed          Journal:  Asia Pac Psychiatry        ISSN: 1758-5864            Impact factor:   2.538


  10 in total

1.  Relationship between job satisfaction, burnout syndrome and depressive symptoms in physicians: a cross-sectional study based on the employment demand-control model using structural equation modelling.

Authors:  David Villarreal-Zegarra; Wilder Iván Lázaro-Illatopa; Ronald Castillo-Blanco; Baltica Cabieses; Alice Blukacz; Luciana Bellido-Boza; Edward Mezones-Holguin
Journal:  BMJ Open       Date:  2022-10-19       Impact factor: 3.006

2.  Psychometric Properties of a Spanish Version of the Fear of COVID-19 Scale in General Population of Lima, Peru.

Authors:  Jeff Huarcaya-Victoria; David Villarreal-Zegarra; Angela Podestà; María Alejandra Luna-Cuadros
Journal:  Int J Ment Health Addict       Date:  2020-06-22       Impact factor: 3.836

3.  Type 2 diabetes mellitus and anxiety symptoms: a cross-sectional study in Peru.

Authors:  Guadalupe Arteaga-Zarate; Gina Demarini-Olivares; Paola A Torres-Slimming; Antonio Bernabe-Ortiz
Journal:  Wellcome Open Res       Date:  2022-05-13

4.  Prevalence and correlates of depressive symptoms among Chinese patients with cataracts treated in tertiary general hospitals.

Authors:  Zhong-Hua Liu; Chang-Zheng Chen; Cong Gao; De-Yi Zhou
Journal:  PeerJ       Date:  2020-06-16       Impact factor: 2.984

5.  The prevalence of depressive and anxiety symptoms and their associations with quality of life among clinically stable older patients with psychiatric disorders during the COVID-19 pandemic.

Authors:  Wen Li; Na Zhao; Xiaona Yan; Siyun Zou; Huan Wang; Yulong Li; Xiuying Xu; Xiangdong Du; Lan Zhang; Qinge Zhang; Teris Cheung; Gabor S Ungvari; Chee H Ng; Yu-Tao Xiang
Journal:  Transl Psychiatry       Date:  2021-01-26       Impact factor: 6.222

6.  Prevalence, Influencing Factors, and Cognitive Characteristics of Depressive Symptoms in Elderly Patients with Schizophrenia.

Authors:  Yaopian Chen; Wei Li
Journal:  Neuropsychiatr Dis Treat       Date:  2021-12-14       Impact factor: 2.570

7.  Validation of the Canadian French version of the fear of COVID-19 scale in the general population of Quebec.

Authors:  Randa Attieh; Kouamé Koffi; Moustapha Touré; Érica Parr-Labbé; Amir H Pakpour; Thomas G Poder
Journal:  Brain Behav       Date:  2022-03-30       Impact factor: 3.405

8.  Association between maternal depression and emotion and behavior regulation in Peruvian children: A population-based study.

Authors:  Akram Hernández-Vásquez; Rodrigo Vargas-Fernández; Fabian Chavez-Ecos; Isabel Mendoza-Correa; José Del-Carmen-Sara
Journal:  Prev Med Rep       Date:  2022-07-01

9.  COVID-19 vaccine acceptance and perceived stigma in patients with depression: a network perspective.

Authors:  Hong Cai; Wei Bai; Xiangdong Du; Ling Zhang; Lan Zhang; Yu-Chen Li; Huan-Zhong Liu; Yi-Lang Tang; Todd Jackson; Teris Cheung; Feng-Rong An; Yu-Tao Xiang
Journal:  Transl Psychiatry       Date:  2022-10-04       Impact factor: 7.989

10.  Short-term trends in the prevalence, awareness, treatment, and control of arterial hypertension in Peru.

Authors:  David Villarreal-Zegarra; Rodrigo M Carrillo-Larco; Antonio Bernabe-Ortiz
Journal:  J Hum Hypertens       Date:  2020-06-09       Impact factor: 3.012

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.